| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.07 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |